StockData
SkinHealth Systems Inc. logo

SkinHealth Systems Inc. (SKIN) stock

SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30316% above fair value
$12.46−1.41 (-10.20%)

Close on Nov 18, 2026Market cap $1.62BP/E –Yield –

SkinHealth Systems operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

SkinHealth Systems's operating income for the twelve months ending Jun 30, 2026 was -$4.31M. For fiscal 2025 it was -$20.80M. The highest annual figure on record is $13.46M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$20.80M–
FY2024Dec 31, 2024-$67.77M–
FY2023Dec 31, 2023-$130.92M–
FY2022Dec 31, 2022-$25.84M–
FY2021Dec 31, 2021-$39.93M–
FY2020Dec 31, 2020-$17.18M-227.6%
FY2019Dec 31, 2019$13.46M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.57M–
Q1 FY2026Mar 31, 2026-$1.80M–
Q4 FY2025Dec 31, 2025$162.00K–
Q3 FY2025Sep 30, 2025-$6.24M–
Q2 FY2025Jun 30, 2025-$2.70M–
Q1 FY2025Mar 31, 2025-$12.02M–
Q4 FY2024Dec 31, 2024-$7.16M–
Q3 FY2024Sep 30, 2024-$21.52M–
Q2 FY2024Jun 30, 2024-$22.11M–
Q1 FY2024Mar 31, 2024-$16.99M–
Q4 FY2023Dec 31, 2023-$18.36M–
Q3 FY2023Sep 30, 2023-$82.10M–
Q2 FY2023Jun 30, 2023-$13.15M–
Q1 FY2023Mar 31, 2023-$17.31M–
Q4 FY2022Dec 31, 2022-$2.45M–
Q3 FY2022Sep 30, 2022-$4.35M–
Q2 FY2022Jun 30, 2022-$5.03M–
Q1 FY2022Mar 31, 2022-$14.01M-688.3%
Q4 FY2021Dec 31, 2021-$10.50M–
Q3 FY2021Sep 30, 2021-$5.46M-295.9%
Q2 FY2021Jun 30, 2021-$26.35M–
Q1 FY2021Mar 31, 2021$2.38M–
Q4 FY2020Dec 31, 2020-$4.71M–
Q3 FY2020Sep 30, 2020$2.79M–
Q2 FY2020Jun 30, 2020-$7.92M–

More SkinHealth Systems figures

See a number that looks wrong?